<p>Repeated haematologic studies are necessary during treatment and for at least 7 wk after discontinuation of the drug. Discontinue use when the leucocyte count decreases to &lt;4000/mm3&nbsp;or the platelet count decreases to &lt;150,000/mm3&nbsp;or if a progressive decline in either occurs. Monitor patient for signs of renal or pulmonary toxicity.</p>